| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Huang,Bai-Xiong | Chairman | 1.26% | |
| Huang,Bai-Xun | Director | 6.20% | |
| Su,Hao-Xi | Director | 0.00% | |
| Yang,Chang-Rui | Director | 2.32% | |
| Zhong,Dai-Rong | Director | 23.85% | YAO SHENG ELECTRONIC CO., LTD. |
| Lan,Ya-Hui | Director | 23.85% | YAO SHENG ELECTRONIC CO., LTD. |
| Su,Xiao-Hui | Director | 23.85% | YAO SHENG ELECTRONIC CO., LTD. |
| Li,Zhi-Heng | Independent Director | 0.00% | |
| Lai,Zong-Cheng | Independent Director | 0.00% | |
| Peng,Sheng-Chao | Independent Director | 0.00% | |
| Li,Wei-Tai | Independent Director | 0.00% |
Change Company Name to JOHNSON & JOHNSON CHEMICAL & PHARMACEUTICALS, INC. (FORMERLY: JOHNSON & JOHNSON CHEMICAL & PHARMACEUTICALS, INC.)
2023/08/15
Change Company Name to JOHNSON CHEMICAL PHARMACEUTICAL WORKS CO., LTD.
2023/08/15
Change Company Name to JOHNSON & JOHNSON CHEMICAL & PHARMACEUTICALS, INC. (FORMERLY: JOHNSON & JOHNSON CHEMICAL & PHARMACEUTICALS, INC.)
2023/06/12
Change Company Name to JOHNSON CHEMICAL PHARMACEUTICAL WORKS CO., LTD.
2023/06/12
Change Company Name to JOHNSON & JOHNSON CHEMICAL & PHARMACEUTICALS, INC. (FORMERLY: JOHNSON & JOHNSON CHEMICAL & PHARMACEUTICALS, INC.)
2022/06/14
Change Company Name to JOHNSON CHEMICAL PHARMACEUTICAL WORKS CO., LTD.
2022/06/14
Change Capital to 700,000,000
2019/06/10
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 146,792 | 611,415 | 606,711 |
| Operating cost | 87,760 | 363,447 | 362,078 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 59,032 | 247,968 | 244,633 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 59,032 | 247,968 | 244,633 |
| Operating expenses | 34,304 | 149,766 | 145,803 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 24,728 | 98,202 | 98,830 |
| Non-operating income and expenses | 2,352 | 10,506 | 2,059 |
| Net profit (loss) before tax | 27,080 | 108,708 | 100,889 |
| Income tax expense (benefits) | 5,492 | 24,585 | 21,189 |
| Net profit (loss) of ongoing business for the current period | 21,588 | 84,123 | 79,700 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 21,588 | 84,123 | 79,700 |
| Other comprehensive profit (loss), net | 1,473 | 2,615 | -3,807 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 23,061 | 86,738 | 75,893 |
| Net profit (loss) attributable to owners of parent company | 21,588 | 84,123 | 79,700 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | 23,061 | 86,738 | 75,893 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 0 | 1 | 2 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 37,035 | 62,877 | 136,950 |
| Net cash inflows (outflows) from investing activities | -8,555 | -12,958 | -33,279 |
| Net cash inflow (outflow) from financing activities | - | -67,471 | 815,467 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | 28,480 | -17,552 | 919,138 |
| Beginning balance of cash and cash equivalents | 1,070,057 | 1,087,609 | 168,471 |
| Ending balance of cash and cash equivalents | 1,098,537 | 1,070,057 | 1,087,609 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 1,354,402 | 1,336,828 | 1,358,764 |
| Non-current asset | 633,211 | 628,437 | 634,178 |
| Total asset | 1,987,613 | 1,965,265 | 1,992,942 |
| Current liability | 169,951 | 171,143 | 220,012 |
| Non-current liability | 90,695 | 90,216 | 100,981 |
| Total liability | 260,646 | 261,359 | 320,993 |
| share capital | 449,324 | 449,324 | 447,210 |
| Equity - secruity token | - | - | - |
| capital reserve | 1,048,698 | 1,048,698 | 1,038,272 |
| retained earning | 239,081 | 217,493 | 196,317 |
| Other equity | -10,136 | -11,609 | -9,850 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 1,726,967 | 1,703,906 | 1,671,949 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 1,726,967 | 1,703,906 | 1,671,949 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 38 | 37 | 38 |
